PDB Short entry for 1A7Y HEADER ANTIBIOTIC 19-MAR-98 1A7Y TITLE CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTINOMYCIN D; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: DACTINOMYCIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES ANTIBIOTICUS; SOURCE 3 ORGANISM_TAXID: 1890 KEYWDS ACTINOMYCIN, ANTIBIOTIC, ANTITUMOR, ANTICANCER, CHROMOPHORE, KEYWDS 2 DEPSIPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHAFER,G.M.SHELDRICK,I.BAHNER,H.LACKNER REVDAT 8 15-NOV-23 1A7Y 1 REMARK LINK ATOM REVDAT 7 13-NOV-19 1A7Y 1 JRNL LINK REVDAT 6 07-MAR-18 1A7Y 1 REMARK REVDAT 5 27-JUL-11 1A7Y 1 REMARK REVDAT 4 13-JUL-11 1A7Y 1 VERSN REVDAT 3 24-FEB-09 1A7Y 1 VERSN REVDAT 2 25-JAN-05 1A7Y 1 JRNL REVDAT 1 23-MAR-99 1A7Y 0 JRNL AUTH M.SCHAFER,G.M.SHELDRICK,I.BAHNER,H.LACKNER JRNL TITL CRYSTAL STRUCTURES OF ACTINOMYCIN D AND ACTINOMYCIN Z3. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 37 2381 1998 JRNL REFN ESSN 1521-3773 JRNL PMID 29710967 JRNL DOI 10.1002/(SICI)1521-3773(19980918)37:17<2381::AID-ANIE2381>3. JRNL DOI 2 0.CO;2-L REMARK 2 REMARK 2 RESOLUTION. 0.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.057 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.058 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.068 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1401 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 14126 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.054 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.055 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.066 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1334 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 13362 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 270 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 314.00 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 318.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 2875 REMARK 3 NUMBER OF RESTRAINTS : 3689 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.000 REMARK 3 ANGLE DISTANCES (A) : 0.000 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.024 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.163 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.000 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.000 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.000 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.006 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.027 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NO RESTRAINTS ON DISTANCES AND ANGLES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY 0.039 REMARK 4 REMARK 4 1A7Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170505. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-97 REMARK 200 TEMPERATURE (KELVIN) : 133 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS HI-STAR REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SADABS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14126 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.940 REMARK 200 RESOLUTION RANGE LOW (A) : 999.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 200 DATA REDUNDANCY : 4.380 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.85 REMARK 200 R MERGE FOR SHELL (I) : 0.07200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: SHELXL-97 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 18.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ACTINOMYCIN D IS A BICYCLIC PEPTIDE, A MEMBER OF THE REMARK 400 ACTINOMYCIN FAMILY. REMARK 400 HERE, ACTINOMYCIN D IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE ACTINOMYCIN D IS POLYPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACTINOMYCIN D REMARK 400 CHAIN: A, B, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: ACTINOMYCIN D CONSISTS OF TWO PENTAMER RINGS LINKED REMARK 400 BY THE CHROMOPHORE (PXZ) REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 106 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE A 107 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE C 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEE C 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF ACTINOMYCIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF ACTINOMYCIN D REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN Z3 REMARK 900 RELATED ID: 209D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF N8-ACTINOMYCIN D COMPLEXED WITH D(GAAGCTTC)2 REMARK 900 RELATED ID: 1UNM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINOACTINOMYCIN D COMPLEXED WITH NON- REMARK 900 COMPLEMENTARY DNA REMARK 900 RELATED ID: 1I3W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CGATCGATCG)2 REMARK 900 RELATED ID: 1FJA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (AAGCGCTT)2 REMARK 900 RELATED ID: 173D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 2D55 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSC RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1L1V RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTNIOMYCIN D COMPLEXED WITH MISMATCHED DNA REMARK 900 (GTCACCGAC) REMARK 900 RELATED ID: 316D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF F8-ACTINOMYCIN D COMPLEXED WITH DNA (GAAGCTTC)2 REMARK 900 RELATED ID: 1DSD RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (GATGCTTC)2 REMARK 900 RELATED ID: 1MNV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (ATGCTGCAT)2 REMARK 900 RELATED ID: 1UNJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 7-AMINO-ACTINOMYCIN D COMPLEXED WITH A NON- REMARK 900 COMPLEMENTARY DNA (TTAGT)2 REMARK 900 RELATED ID: 1OVF RELATED DB: PDB REMARK 900 SOLUTIOM STRUCTURE OF ACTINOMYCIN D COMPLEXED WITH DNA (CCGTTTTGTGG) REMARK 900 2 REMARK 900 RELATED ID: 1QFI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTINOMYCIN X2 DBREF 1A7Y A 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1A7Y B 1 11 NOR NOR00228 NOR00228 1 11 DBREF 1A7Y C 1 11 NOR NOR00228 NOR00228 1 11 SEQRES 1 A 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 B 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA SEQRES 1 C 11 THR DVA PRO SAR MVA PXZ THR DVA PRO SAR MVA HET DVA A 2 7 HET SAR A 4 5 HET MVA A 5 8 HET PXZ A 6 22 HET DVA A 8 7 HET SAR A 10 5 HET MVA A 11 8 HET DVA B 2 7 HET SAR B 4 5 HET MVA B 5 8 HET PXZ B 6 22 HET DVA B 8 7 HET SAR B 10 5 HET MVA B 11 8 HET DVA C 2 7 HET SAR C 4 5 HET MVA C 5 8 HET PXZ C 6 22 HET DVA C 8 7 HET SAR C 10 5 HET MVA C 11 8 HET EEE A 104 6 HET EEE A 105 6 HET EEE A 106 6 HET EEE A 107 6 HET EEE C 101 6 HET EEE C 102 6 HET EEE C 103 6 HET MOH C 108 2 HETNAM DVA D-VALINE HETNAM SAR SARCOSINE HETNAM MVA N-METHYLVALINE HETNAM PXZ 2-AMINO-1,9-DICARBONYL-4,6-DIMETHYL-10-DEHYDRO- HETNAM 2 PXZ PHENOXAZIN-3-ONE HETNAM EEE ETHYL ACETATE HETNAM MOH METHANOL HETSYN PXZ PHENOXAZINE FORMUL 1 DVA 6(C5 H11 N O2) FORMUL 1 SAR 6(C3 H7 N O2) FORMUL 1 MVA 6(C6 H13 N O2) FORMUL 1 PXZ 3(C16 H12 N2 O4) FORMUL 4 EEE 7(C4 H8 O2) FORMUL 11 MOH C H4 O LINK C THR A 1 N DVA A 2 1555 1555 1.34 LINK OG1 THR A 1 C MVA A 5 1555 1555 1.35 LINK N THR A 1 C0 PXZ A 6 1555 1555 1.36 LINK C DVA A 2 N PRO A 3 1555 1555 1.35 LINK C PRO A 3 N SAR A 4 1555 1555 1.34 LINK C SAR A 4 N MVA A 5 1555 1555 1.35 LINK C0' PXZ A 6 N THR A 7 1555 1555 1.35 LINK C THR A 7 N DVA A 8 1555 1555 1.33 LINK OG1 THR A 7 C MVA A 11 1555 1555 1.36 LINK C DVA A 8 N PRO A 9 1555 1555 1.36 LINK C PRO A 9 N SAR A 10 1555 1555 1.34 LINK C SAR A 10 N MVA A 11 1555 1555 1.35 LINK C THR B 1 N DVA B 2 1555 1555 1.35 LINK OG1 THR B 1 C MVA B 5 1555 1555 1.35 LINK N THR B 1 C0 PXZ B 6 1555 1555 1.35 LINK C DVA B 2 N PRO B 3 1555 1555 1.35 LINK C PRO B 3 N SAR B 4 1555 1555 1.35 LINK C SAR B 4 N MVA B 5 1555 1555 1.35 LINK C0' PXZ B 6 N THR B 7 1555 1555 1.33 LINK C THR B 7 N DVA B 8 1555 1555 1.34 LINK OG1 THR B 7 C MVA B 11 1555 1555 1.34 LINK C DVA B 8 N PRO B 9 1555 1555 1.35 LINK C PRO B 9 N SAR B 10 1555 1555 1.35 LINK C SAR B 10 N MVA B 11 1555 1555 1.35 LINK C THR C 1 N DVA C 2 1555 1555 1.34 LINK OG1 THR C 1 C MVA C 5 1555 1555 1.37 LINK N THR C 1 C0 PXZ C 6 1555 1555 1.36 LINK C DVA C 2 N PRO C 3 1555 1555 1.34 LINK C PRO C 3 N SAR C 4 1555 1555 1.36 LINK C SAR C 4 N MVA C 5 1555 1555 1.35 LINK C0' PXZ C 6 N THR C 7 1555 1555 1.34 LINK C THR C 7 N DVA C 8 1555 1555 1.35 LINK OG1 THR C 7 C MVA C 11 1555 1555 1.35 LINK C DVA C 8 N PRO C 9 1555 1555 1.34 LINK C PRO C 9 N SAR C 10 1555 1555 1.37 LINK C SAR C 10 N MVA C 11 1555 1555 1.36 CISPEP 1 DVA A 2 PRO A 3 0 15.27 CISPEP 2 PRO A 3 SAR A 4 0 -4.60 CISPEP 3 DVA A 8 PRO A 9 0 19.55 CISPEP 4 PRO A 9 SAR A 10 0 -14.77 CISPEP 5 DVA B 2 PRO B 3 0 14.29 CISPEP 6 PRO B 3 SAR B 4 0 -7.25 CISPEP 7 DVA B 8 PRO B 9 0 18.82 CISPEP 8 PRO B 9 SAR B 10 0 -9.46 CISPEP 9 DVA C 2 PRO C 3 0 15.67 CISPEP 10 PRO C 3 SAR C 4 0 -17.54 CISPEP 11 DVA C 8 PRO C 9 0 10.99 CISPEP 12 PRO C 9 SAR C 10 0 -3.54 SITE 1 AC1 5 DVA A 8 EEE A 105 PRO C 3 PXZ C 6 SITE 2 AC1 5 EEE C 101 SITE 1 AC2 4 THR A 1 THR A 7 EEE A 104 SAR B 10 SITE 1 AC3 3 MVA A 5 THR A 7 PXZ C 6 SITE 1 AC4 6 PRO A 3 DVA B 2 PRO B 3 THR C 1 SITE 2 AC4 6 PXZ C 6 PRO C 9 SITE 1 AC5 2 EEE A 104 MVA C 5 SITE 1 AC6 6 SAR A 10 THR B 1 MVA B 5 PXZ B 6 SITE 2 AC6 6 PRO C 3 EEE C 103 SITE 1 AC7 6 MVA B 5 PXZ B 6 DVA B 8 PRO C 9 SITE 2 AC7 6 MVA C 11 EEE C 102 SITE 1 AC8 14 EEE A 104 EEE A 105 EEE A 106 EEE A 107 SITE 2 AC8 14 THR B 1 PXZ B 6 THR B 7 PRO B 9 SITE 3 AC8 14 MVA B 11 PRO C 3 SAR C 4 MVA C 5 SITE 4 AC8 14 PXZ C 6 EEE C 102 SITE 1 AC9 15 THR A 1 PXZ A 6 THR A 7 PRO A 9 SITE 2 AC9 15 MVA A 11 EEE A 105 EEE A 107 DVA C 2 SITE 3 AC9 15 PXZ C 6 DVA C 8 PRO C 9 SAR C 10 SITE 4 AC9 15 MVA C 11 EEE C 102 EEE C 103 SITE 1 BC1 16 DVA A 2 PRO A 3 SAR A 4 MVA A 5 SITE 2 BC1 16 PXZ A 6 EEE A 104 EEE A 106 EEE A 107 SITE 3 BC1 16 PRO B 3 MVA B 5 PXZ B 6 DVA B 8 SITE 4 BC1 16 MVA B 11 EEE C 101 EEE C 102 EEE C 103 CRYST1 15.737 15.887 25.156 85.93 86.19 69.86 P 1 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.063545 -0.023304 -0.003039 0.00000 SCALE2 0.000000 0.067044 -0.003447 0.00000 SCALE3 0.000000 0.000000 0.039893 0.00000